Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia

10 Sept 2015

Abstract excerpt

// Siddhartha Ganguly 1, * , Trisha Home 1, * , Abdulraheem Yacoub 1 , Suman Kambhampati 1 , Huidong Shi 2 , Prasad Dandawate 1 , Subhash Padhye 3 , Ashok K. Saluja 4 , Joseph McGuirk 1 , Rekha Rao 1 1 The University of Kansas Cancer Center, Kansas City, KS, USA 2 Georgia Regents University, Augusta, GA, USA 3 Interdisciplinary Science and Technology Research Academy, University of Pune, Maharashtra, India 4...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to Endoplasmic Reticulum Stress and Disease
Share to Heat shock proteins research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26397138
DOI: 10.18632/oncotarget.5167

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemiaPMID 26397138Read ↗

Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemiaSemantic proximity Read ↗

HSF1, a versatile factor in tumorogenesis.Semantic proximity Read ↗

Heat shock protein 90Semantic proximity Read ↗

Chaperoning STAT3/5 by Heat Shock Proteins: Interest of Their Targeting in Cancer TherapySemantic proximity Read ↗

The novel Hsp-90 inhibitor SNX7081 is significantly more potent than 17-AAG against primary CLL cells and a range of haematological cell lines, irrespective of lesions in the TP53 pathway.Semantic proximity Read ↗

A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphomaSemantic proximity Read ↗

HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based RegimenSemantic proximity Read ↗

The Hsp90 inhibitor SNX-7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human, p53-negative chronic lymphocytic leukemia.Semantic proximity Read ↗

HSP90 and HSP70: Implication in Inflammation Processes and Therapeutic Approaches for Myeloproliferative NeoplasmsSemantic proximity Read ↗

Heat shock protein-90 inhibitor, NVP-AUY922, is effective in combination with fludarabine against chronic lymphocytic leukemia cells cultured on CD40L-stromal layer and inhibits their activated/proliferative phenotype.Semantic proximity Read ↗

HSF1 deficiency and impaired HSP90-dependent protein folding are hallmarks of aneuploid human cells.Semantic proximity Read ↗

Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLLSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.